Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung Source: Eur Respir J 2006; 28: 275-285 Year: 2006
Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-α release from human alveolar macrophages Source: Eur Respir J 2007; 29: 986-994 Year: 2007
Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro Source: Eur Respir J 2008; 31: 118-125 Year: 2008
TACE/TGF-?/EGFR regulates CXCL8 in bronchial epithelial cells exposed to particulate matter components Source: Eur Respir J 2011; 38: 1189-1199 Year: 2011
Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9 Source: Eur Respir J 2002; 20: 1198-1205 Year: 2002
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011
Free, soluble interleukin-17 protein during severe inflammation in human airways Source: Eur Respir J 2002; 19: 534-537 Year: 2002
Induction of TGF-β and reactive oxygen species expression in bronchial epithelial cell by urban ambient air particulate matter Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches Year: 2006
The role of oxidative stress and pro-inflamatory cytokines in exogenous toxic alveolites (ETA) Source: Annual Congress 2007 - Considerations in the therapeutic approach of interstitial lung disease: oxidative stress and inflammation Year: 2007
An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005
Cilomilast, a second generation phosphodiestease 4 inhibitor, in combination with PGE2 attenuates fMLP, IL-8 and cigarette smoke-induced effects on the mechanical and functional properties of neutrophils Source: Eur Respir J 2001; 18: Suppl. 33, 161s Year: 2001
Eosinophil cationic protein stimulates TGF-β1 release by human lung fibroblasts Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005
Involvement of nitric oxide, proinflammatory cytokines and effector cells in the inflammatory process in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005
iNOS depletion completely diminishes reactive nitrogen-species formation after an allergic response Source: Eur Respir J 2002; 20: 609-616 Year: 2002
Induction of pro-inflammatory mediator release by cigarette smoke condensate: differential effects on alveolar epithelial cells and macrophages Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003
α,β-unsaturated aldehydes contained in cigarette smoke elicit release of inflammatory mediators from human macrophages Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007
Development of new treatments for complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006
Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Role of lipid mediators and nitric oxide (NO) in the immediate lung response to lipopolysaccharide Source: Eur Respir J 2002; 20: Suppl. 38, 228s Year: 2002
Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis Source: Eur Respir J 2003; 21: 925-931 Year: 2003